Table 1.
Initial disease classification of patient |
Gender | Age of onset (years) |
First evalua- tion (age, years) |
Time from onset to last EMG (months) |
Final disease classification |
Functional outcome |
---|---|---|---|---|---|---|
PUMND | ||||||
1 | M | 62 | 62 | 29 | PUMND | WA |
2 | M | 44 | 44 | 50 | PUMND | FA |
3 | M | 45 | 47 | 25 | PUMND | FA |
4 | F | 33 | 33 | 72 | PUMND | FA |
5 | M | 71 | 72 | 29 | PUMND | WA |
6 | F | 74 | 76 | 17 | PUMND | WC, NIV |
7 | F | 74 | 76 | 95 | PUMND | FA |
8 | M | 34 | 36 | 28 | PUMND | FA |
9 | F | 59 | 62 | 90 | PUMND | WA |
10 | M | 62 | 66 | 51 | PUMND | FA |
11 | F | 54 | 58 | 57 | PUMND | FA |
12 | M | 54 | 60 | 76 | PUMND | WA |
13 | F | 31 | 39 | 97 | PUMND | FA |
14* | M | 38 | 41 | 37 | PUMND | WA |
15* | F | 43 | 60 | 198 | PUMND | WA |
Summary, PUMND |
8 M 7 F |
51.8 (range,33– 74) |
55.5 (range, 33–76) |
63.4 (range, 17–198) |
PUMND |
FA = 8† WA = 6† WC = 1† NIV = 1 |
PUMND +LMND | ||||||
16 | M | 48 | 48 | 82 | PUMND + LMND |
WA |
17 | F | 48 | 49 | 41 | PUMND + LMND |
WC (Dec) |
18 | F | 46 | 49 | 38 | PUMND + LMND |
WA |
19 | M | 62 | 64 | 86 | PUMND + LMND |
WA |
20 | M | 45 | 48 | 41 | PUMND + LMND |
WA |
21 | F | 58 | 61 | 43 | PUMND + LMND |
WA |
22 | F | 53 | 61 | 102 | PUMND + LMND |
WC, NIV |
23 | F | 55 | 66 | 64 | PUMND + LMND |
WC, NIV |
Summary, PUMND + LMND |
3 M 5 F |
51.8 (range, 46–62) |
55.7 (range, 48–66) |
62.1 (range, 38–102) |
PUMND + LMND |
FA = 0† WA = 5 WC = 3 NIV = 2 Dec = 1 |
Dec=deceased, FA=full ambulation, LMND=lower motor neuron disease/dysfunction, NIV=non-invasive ventilation, PUMND=pure upper motor neuron disease, WA=walker, WC=wheelchair.
had only one EMG.
P = 0.02 (2 by 3 Fisher Exact Test for the full ambulation, walker, and wheelchair groups).